Response to: High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab by Conticini et al #MMPMID32816700
Ramiro S; Mostard R; Landewe RB
Ann Rheum Dis 2022[Oct]; 81 (10): e203 PMID32816700show ga